SCHEMBL13990933

SCHEMBL13990933

CCC(O)C(C)OC(O)[C@H](C)O

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.39
TRPA1 O75762 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9011656 0.80 TSHR (0.36) TSHR
SCHEMBL27489045 0.76 TSHR (0.41) TSHR
SCHEMBL26133661 0.76 TSHR (0.63) TSHR
SCHEMBL556307 0.73 ALDH1A1 (0.39) TSHR
SCHEMBL23080051 0.72
SCHEMBL7166098 0.72
SCHEMBL9351704 0.72 TSHR (0.38) TSHR
SCHEMBL15267652 0.72 TSHR (0.33) TSHR
SCHEMBL13990930 0.70
SCHEMBL1960695 0.70 TSHR (0.41) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080299164-A1 Substituted polycaprolactone for coating ABBOTT CARDIOVASCULAR SYSTEMS INC. 2008-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080299164-A1 Substituted polycaprolactone for coating PCBP1, PUF60, COL14A1 TSHR 4651/4885TRPA1 4733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.